Skip to content

Clinical trials

Phase 2/3 Stroke trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2/3 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20171
20182
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capital Medical University4
Beijing Tiantan Hospital2
Fudan University1
Nanfang Hospital, Southern Medical University1
Xijing Hospital1
Xinqiao Hospital of Chongqing1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke10
Ischemic Stroke5
Cerebral Infarction2
Brain Edema1
Cerebral Hemorrhage1
Hemorrhagic Stroke1
Hypothermia1
Infections1
Intracranial Arteriosclerosis1
Intracranial Hemorrhages1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.